MHRA suspends recruitment to COVID-19 hydroxychloroquine trials
Press release The Medicines and Healthcare products Regulatory Agency (MHRA) has instructed UK clinical trialists using hydroxychloroquine to treat or prevent coronavirus (COVID-19) to suspend recruitment of further participants. This means … read more